Dr. Benjamin Philip Levy

Dr. Benjamin Levy waa khabiir ku takhasusay kansarka laf-dhabarka kaas oo sidoo kale u adeega agaasimaha kiliinikada ee Oncology ee Johns Hopkins Sidney Kimmel Xarunta Kansarka ee Sibley Memorial Hospital iyo associate professor of oncology at Johns Hopkins University School of Medicine. Wuxuu ka shaqeeyaa Isbitaalka Sibley Memorial ee Johns Hopkins Sidney Kimmel Xarunta Kansarka.

Dr. Levy is a clinician scientist who is interested in novel immunotherapeutic treatments for patients with advanced kansarka sanbabada, as well as biomarkers that help identify those patients who are more likely to respond to such medicines. He specialises in thoracic malignancies such as non-small cell lung cancer, small cell lung cancer, thymic malignancies, and kansarka madaxa iyo qoorta.

Dr. Levy graduated from the Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Centre, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his kansarka qanjirka 'prostate clinical research. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, as the medical director of thoracic oncology for Mount Sinai Health Systems, and as the associate director of Mount Sinai Hospital’s Cancer Dhibaatooyinka Daaweynta Xafiiska.

Dr. Levy wuxuu ka soo shaqeeyay guddiyo badan oo American Society of Clinical Oncology (ASCO) wuxuuna hadda yahay tifaftire ku-xigeenka Guddiga Jaamacadda ASCO. Waxa uu ka soo shaqeeyay guddiga tifaftirka ee Joornaalka Oncology Clinic muddo laba sano ah oo hadda waa dib-u-eegis ku-meel-gaar ah oo loogu talagalay daabacado dheeraad ah sida Kansarka sambabada ee Clinical, Oncologist, iyo bartilmaameed Onco. Dr. Levy ayaa dhawaan loo doortay mid ka mid ah 15-ka dhakhaatiirta kansarka ee dalka si uu uga qayb qaato barnaamijka horumarinta hoggaanka ASCO ee sharafta leh, kaas oo ujeedadiisu tahay in la ogaado oo la tababaro hoggaamiyeyaasha ASCO mustaqbalka. Dr. Levy wuxuu kaloo ka shaqeeyaa Guddiga Neefsiga ee ALLIANCE, Guddiga Diyaarinta IASLC, iyo Guddiga Horumarinta Shaqada & Xiriirka Shaqada ee IASLC marka lagu daro howlihiisa ASCO.

• Kansarka sanbabada
• immunotherapy

Becker DJ, Wisnivesky JP, Grossbard ML, Chachoua A, Camidge DR, Levy BP. "Badbaadada Haweenka Aasiyaanka ah ee qaba Kansarka Sambabada Sare ee xilligii Tyrosine Kinase Inhibitor Therapy." Kansarka Sambabka Clin. 2017 Jan; 18 (1): e35-e40. doi: 10.1016/j.cllc.2016.08.008.

Levy BP, Rao P. Dhakhtar (Williston Park). 2016 Jul;30 (7): 601-12. Dib u eegis

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. "Tijaabada Molecular ee Daaweynta Kansarka Sambabka ee Unugyada Yaryar ee Metastatic: Sida Loo Fuliyo Talooyinka Ku Salaysan Caddayn." Oncologist. 2015 Oct;20 (10):1175-81. doi: 10.1634 / theoncologist.2015-0114.

Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS . "Dhaqdhaqaaqa iyo badbaadada nivolumab, ka-hortagga isbaarada difaaca difaaca ee PD-1, ee bukaanada qaba kansarka sanbabada ee aan-unugga yareyn, ee ka soo horjeeda (CheckMate 063): marxaladda 2, tijaabo hal gacan ah." Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9.

Levy BP, Becker DJ. "Waqtiga baarista kombiyuuterka ee qiyaas yar ayaa hadda ah: aragtida dhakhtarka kansarka." Dhakhtar (Williston Park). 2014 Nof;28 (11): 964-6. Ma jiraan wax la taaban karo